Skip to main content
padlock icon - secure page this page is secure

Free Content Correspondence

Download Article:
(PDF 97 kb)
Is second-line anti-tuberculosis drug susceptibility testing reliable? S. J. Kim and M. A. Espinal, Stop TB Department, Tuberculosis Strategy and Operations, World Health Organization, Geneva, Switzerland; C. Abe, Research Institute of Tuberculosis, Japan Anti-TB Association, Tokyo, Japan; G. H. Bai, Korean Institute of Tuberculosis, Korean National TB Association, Seoul, Korea; F. Boulahbal, Laboratoire de la Tuberculose, Institut Pasteur d'Algérie-Alger, Alger, Algeria; L. Fattorini, Instituto Superiore de Sanita Laboratory of Bacteriology & Medical Mycology, Rome, Italy; C. Gilpin, Queensland Mycobacterium Reference Laboratory, The Prince Charles Hospital, Queensland Health, Brisbane, Australia; S. Hoffner, Swedish Institute for Infectious Disease Control, Solna, Sweden; K. M. Kam, Tuberculosis Reference Laboratory, Public Health Laboratory Complex, Department of Health, Hong Kong, China; N. Martin-Casabona, Servei de Microbiologia Hospita, Universitarie Vall d'Hebron, Barcelona, Spain; L. Rigouts, Department of Micobiology, Mycobacteriology Unit Institute of Tropical Medicine, Antwerpen, Belgium; and V. Vincent, Centre National de Référence des Mycobactéries Institut Pasteur, Paris, France
No Reference information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Letter Paper

Publication date: September 1, 2004

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

    Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more